Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Appili Therapeutics Inc. — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Appili Therapeutics Amends Arrangement Agreement and Increases Bridge Loan

Jul 02, 2024•almost 2 years ago

Contract Type

agreement

HalifaxBiotechnologyHealth CareScience And Engineering

Description

Appili Therapeutics Inc. announces the amendment of the arrangement agreement with Aditxt, Inc. and Adivir, Inc., extending the Outside Date and other deadlines to August 30, 2024. Additionally, the company has increased the principal amount of its unsecured bridge financing.

Company Information

Company

Appili Therapeutics Inc.

Location

21-1344 SUMMER ST.

Halifax, England, United Kingdom

About

Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.

Predictive Intelligence
Strategic

ML-powered predictions for Appili Therapeutics Inc.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months